3α,21-Dihydroxy-5α-pregnan-20-one
CAS No. 567-02-2
3α,21-Dihydroxy-5α-pregnan-20-one ( —— )
产品货号. M34145 CAS No. 567-02-2
3α,21-Dihydroxy-5α-pregnan-20-one (THDOC),是一种内源性神经甾体,是 GABAA 受体的正向调节剂。3α,21-Dihydroxy-5α-pregnan-20-one (THDOC) 增强神经元对低浓度 α4β1δ GABAA 受体的反应。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥1925 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称3α,21-Dihydroxy-5α-pregnan-20-one
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述3α,21-Dihydroxy-5α-pregnan-20-one (THDOC),是一种内源性神经甾体,是 GABAA 受体的正向调节剂。3α,21-Dihydroxy-5α-pregnan-20-one (THDOC) 增强神经元对低浓度 α4β1δ GABAA 受体的反应。
-
产品描述3α,21-Dihydroxy-5α-pregnan-20-one (THDOC), an endogenous neurosteroid, is a positive modulator of GABAA receptors. 3α,21-Dihydroxy-5α-pregnan-20-one potentiates neuronal response to low concentrations of GABA at α4β1δ GABAA receptors in vitro.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体GABA Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number567-02-2
-
分子量334.49
-
分子式C21H34O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 100 mg/mL (298.96 mM; 超声助溶 )
-
SMILES[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)CC[C@]12C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
MSP-1 P2, Malaria Me...
MSP-1 P2, Malaria Merozoite Surface Peptide – 1
-
MERS-CoV-IN-1
MERS-CoV-IN-1对冠状病毒表现出优异的抑制活性。它可用作预防冠状病毒诱发的疾病(MERS-CoV和SARS)的化合物组合物。
-
Fibrinogen-Binding P...
Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen, a soluble plasma protein, is a cofactor in platelet activation. It is converted to fibrin in a reaction catalyzed by thrombin.
021-51111890
购物车()
sales@molnova.cn

